Our purpose was to characterize the excitable gap during atrioventricular nodal reentrant tachycardia (AVNRT) to elucidate the electrophysiologic substrate of this clinically familiar microreentrant arrhythmia. Accordingly, in 11 patients with classic slow-fast AVNRT (mean cycle length, 342±41 msec), a single ventricular extrastimulus (V2) was periodically delivered after a spontaneous tachycardia beat (V1) until ventricular refractoriness was reached. With this technique, an excitable gap was considered present when atrial preexcitation of at least 20 msec could be achieved along with tachycardia resetting (noncompensatory pause after V2). The range of V1V2 intervals that resulted in atrial preexcitation constituted the preexcitation zone.
Five patients (45%) showed evidence of an excitable gap at baseline, with a maximal atrial preexcitation achievable of 33±6 msec, representing 9±1% of the tachycardia cycle length. Verapamil was then administered to all 11 patients with the purpose of slowing the anterograde tachycardia wavefront before arrival of V2. This resulted in widening of the preexcitation zone in three patients by a mean of 50±37 msec, with a corresponding increase in maximal atrial preexcitation to 70±32 msec, or 16±4% of AVNRT cycle length, and the appearance of atrial preexcitation in two patients who lacked it during baseline. In the remaining six patients, AVNRT was not sustained after verapamil or was too unstable for evaluation. During baseline, V2A2 conduction time increased by only 5±3 msec throughout the preexcitation zone, with values at the outer border unchanged after verapamil, implying a fully excitable gap in the retrograde limb. In all patients with a preexcitation zone, AVNRT was consistently reset by V2, both at baseline and after verapamil, with a "flat" but mainly "increasing" response A2Ar (return cycle) was at least 10 msec less than two AVNRT cycle lengths (i.e., the pause after the preexcited atrial deflection was less than fully compensatory). This is to be distinguished from the term "resetting response pattern,"29 which is used to describe the relation between the return cycle and V1V2 throughout the preexcitation zone. During tachycardia, after the whole diastole was scanned and the presence or absence of an excitable gap was determined at baseline, all patients were infused with intravenous verapamil (1-2 mg over 1 minute repeated at 3-5-minute intervals; total dose not exceeding 10 mg) during tachycardia to prolong the tachycardia cycle length by at least 20 msec. After stability of the cycle length was achieved, ventricular extrastimuli were again delivered starting in late diastole with 10-msec decrements until ventricular refractoriness. The presence of an excitable gap, outer and inner preexcitation zones, and characteristics of the return cycle were again assessed.
Statistical Analysis
All values are given as mean±SD. Student's paired and unpaired t test and nonparametric Spearman's correlation coefficient analysis were used when applicable. A p value of less than 0.05 was considered statistically significant.
Results
Eleven consecutive patients presenting with AVNRT satisfied the inclusion criteria and were included in our study. There were two men and nine women (mean age, 47±20 years). The mean tachycardia cycle length for the entire group was 342±41 msec (range, 290-420 msec), mean AH was 301±37 msec (range, 245-380 msec), and HA was 41+13 msec (range, 20-65 msec). The mean AH/HA ratio was 8±3 (range, 4.7-13.5) and the mean VA interval (at the HRA) was 48±21 msec (range, 0-80 msec).
Atrial Preexcitation in A VNRT During Baseline Study
As indicated in Table 1 , five patients exhibited atrial preexcitation during the baseline study (patients 1-5; Figure 1 ). The mean tachycardia cycle length in patients with compared to those patients without evidence of an excitable gap was slightly longer, but the difference did not reach statistical significance (364±40 vs. 324+32 msec; p=NS). Also, there was no difference in the AH/ HA ratio between the two groups. The V1V2 interval, preexcited atrial interval (A1A2), and conduction time of the ventricular extrastimuli (V2A2, measured at the HRA level) for both the outer and inner borders of the preexcitation zone are provided in Table 1 . In every case, the inner border of the preexcitation zone at baseline corresponded to the shortest achievable V1V2 before the ventricular effective refractory period. Thus, with the V2 technique, the full extent of the excitable gap could not be defined because of ventricular refractoriness. However, the fact that the maximal preexcitation achievable (max AAA) in the five patients with evidence of atrial preexcitation at baseline was 33 ± 6 msec (range, 25-40 msec) established a minimum estimate for the excitable gap duration, namely, 9±1% (range, 8-11%) of the tachycardia cycle length.
Verapamil Administration
After completion of the baseline study, verapamil was administered during the ongoing tachycardia to all 11 patients. After a mean dose of 5.8±3 mg (range, 2-10 mg) verapamil, AVNRT cycle length prolonged by a mean of 60±34 msec (range, 20-105 Of the five patients in whom the tachycardia was sustained after verapamil, three (patients 1-3) had evidence of atrial preexcitation during baseline studies. The outer border of the preexcitation zone after verapamil was extended by a mean of 50±37 msec (range, 10-100 msec) in all three patients (i.e., atrial preexcitation was now elicited at a longer V1V2 coupling interval) (Figure 2 ). The inner border was still limited by the ventricular effective refractory period, which increased by a mean of only 14±5 msec (range, 10-20 msec) owing to the longer tachycardia cycle lengths after verapamil. As a result, the overall preexcitation zone became wider (Table 1) . Moreover, the maximal atrial preexcitation achievable after verapamil in these patients was 70±32 msec (range, msec) or 16±4% of the tachycardia cycle length, representing increases of 33±30 msec (range, 5-75 msec), or 6±4% (range, 1-11%) of the tachycardia cycle length, respectively, from the baseline values.
The remaining two patients (6 and 7) had no atrial preexcitation during the baseline study but, after verapamil, showed atrial preexcitation induced by V2 (with maximal achievable preexcitation of 65 and 25 msec, respectively), indicating the presence of an excitable gap (Figure 3) .
For the three patients in whom the preexcitation zone widened after verapamil administration, the increase in the zone's outer border (AV1V2) correlated well with the increase in A1H1 (AA1H1) of the tachycardia, as depicted in Figure 4 . For the two patients who manifested atrial preexcitation only after verapamil, AV1V2 was calculated by subtracting the V1V2 interval at the outer border of the preexcitation zone (after verapamil) from the ventricular effective refractory period at baseline. When these values were included with the other plots of AV1V2 against AA1H1, all five points fell close to the line of identity ( Figure  4 ), suggesting that in the last two cases, the shortest V1V2 achievable during baseline studies was just beyond the outer border of the preexcitation zone (which was then extended by verapamil).
V2A2 Conduction Time Within the Preexcitation Zone
To assess the extent of electrical recovery of the retrograde pathway throughout the preexcitation zone, retrograde V2A2 conduction times during baseline and after verapamil administration were measured. For the whole population with evidence of an excitable gap, V2A2 conduction time from outer to inner borders of the preexcitation zone increased by a mean of only 5 ±3 msec (range, 0-10 msec) during baseline and by 13±7 msec (range, 5-25 msec) after verapamil. Figure 5 shows a representative example of such a flat response. V1V2 intervals are plotted against V2A2 conduction time. During the baseline study, there is no V2A2 prolongation over a 40 -msec preexcitation zone. After verapamil administration, there is only a 10 -msec increment in V2A2 over a than the tachycardia cycle length (except in two patients where it was not prolonged at the outer border). At the same time, A2Ar was never fully compensatory, indicating that the V2 impulse consistently reset the tachycardia (Figures 1-3 To assess the return cycle dynamics with increasing degrees of prematurity, investigators29,30 have plotted the return cycle against the coupling intervals of extrastimuli introduced during a tachycardia. In this way, several specific resetting response patterns have been defined, namely "increasing," "decreasing," "flat," or "mixed."29 During baseline studies, both flat and mildly increasing patterns were observed, although due to the very short duration of the preexcitation zone (16+8 msec; range, 10-30 msec), the mean overall change in A2Ar did not reach statistical significance ( Figure  6 ). After verapamil administration, however, the preexcitation zone became significantly broader (68±32 msec; range, 10-100 msec) and, when plotted against VIV2, a definite increasing A2Ar response Figure 7 schematically depicts the status of the circulating AVNRT wavefront with its tail of absolute refractoriness (dashed line) at various times as viewed from the vantage point of the V2 impulse as it attempts to penetrate the circuit. In Panel A, at a V1V2 coupling interval of X, access to the circuit is preempted by the circulating impulse. At an earlier time (X-A1), V2 reaches the distal entry site of the circuit ahead of the circulating impulse, and finds the retrograde limb recovered (Panel B), thereby defining the outer border of the preexcitation zone (and onset of the excitable gap accessible to V2). The shortest achievable V1V2 (X-A2) associated with atrial preexcitation is typically limited by ventricular refractoriness and constitutes the inner border of the zone (Panel C).
We hypothesized that if an adequate delay could be achieved in the anterograde propagation of the tachycardia wavefront, the excitable gap could become accessible (and atrial preexcitation elicited) at a V1V2 coupling interval that failed to do so before that anterograde delay was achieved (conversion from Panel A to Panel D). Indeed, just such an effect occurred in three patients with atrial preexcitation at baseline and persistent, but slower, AVNRT after verapamil: the outer border of the preexcitation zone was extended (by Al in Panel D compared with Panel B). Overall duration of the preexcitation zone widened because the ventricular effective refractory period, which limited the inner border, changed minimally (Panel F). This finding clearly indicated a greater accessibility of V2 to the excitable gap, but it cannot be stated whether the gap itself actually widened after verapamil because ventricular refractoriness prevented delineation of the true inner temporal border of the excitable gap (at some time earlier than X-A2).
Patients who did not exhibit atrial preexcitation at baseline tended to have shorter AVNRT cycle lengths than those who did, confirming previous observations.25 The fact that an atrial preexcitation zone appeared in two of these patients after verapamil suggested the possibility that the excitable gap had been inaccessible in these two cases at baseline because ventricular refractoriness supervened (before V2 could arrive at the distal entry point of the circuit ahead of the anterogradely propagating impulse). This situation is similar to conversion from Panel A to Panel D in Figure 7 , 
Limitations
In six patients, verapamil administration resulted in nonsustained or unstable tachycardia that prevented testing for the potential presence, widening, or unmasking of an excitable gap. Use of alternative agents that could be more efficiently titrated or with shorter serum half-lives might overcome this limitation. Moreover, use of a stimulation site closer to the AVNRT circuit or delivery of double ventricular extrastimuli would also likely increase the "yield" of atrial preexcitation45'46 and allow broader preexcitation zones for the study of unmasking phenomena as well as return cycle dynamics.
As stated above, a retrograde H2 could not be discerned within the V2 electrogram; consequently, an H2Hr interval, as a more precise measure of the return cycle, could not be directly assessed. We chose A2Ar (on the HRA electrogram) as an indirect measure of the return cycle in light of the constancy of relation of the various atrial electrograms associated with A1, A2, and Ar. Use of A2 Ar also offered a distinct advantage over V2Vr because V2H2 and HrVr are unlikely to be identical,47 whereas both A2 and Ar are orthodromically generated. Moreover, A2Ar provided a lower limit estimate for the true return cycle registered at the distal entry point of V2 into the circuit; consideration of this interval obviated the problem of possible asymmetric retrograde compared with anterograde lower common pathway conduction inherent in using H2Hr. Hence, an increasing A2Ar pattern of necessity implied an increasing response in the true return cycle.
Clinical Implications
Although not directly proven, our findings suggest that AVNRT is often due to reentry along a discrete anatomically defined microreentry circuit. Thus, our observations can provide an appealing theoretic framework for the interpretation of recent reports of successful surgical or catheter ablation of the tachyarrhythmia. [17] [18] [19] 48, 49 Finally, the ability to actively influence an excitable gap by pharmacologic means, as demonstrated herein, supports the use of such an approach for investigating other elusive reentry circuits in humans. 50,5' 
